1320.9000 30.30 (2.35%)
NSE Jun 06, 2025 15:31 PM
Volume: 2.2M
 

KRChoksey
During Q4FY25, Dr. Reddy’s revenue stood at INR 85,284 Mn, up 19.9% YoY (+1.8% QoQ), above our estimates by 3.6%, driven by growth across key markets.
EBITDA stood at INR 20,747 Mn, up by 14.4% YoY (-8.7% QoQ), below our estimates by 7.0%, led by contraction in gross margins.
Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended